Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Stefan A. Dyckerhoff sold 30,000 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $105.90, for a total transaction of $3,177,000.00. Following the completion of the sale, the director now owns 3,765 shares in the company, valued at $398,713.50. This represents a 88.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Astera Labs Price Performance
Shares of ALAB stock traded down $1.83 during mid-day trading on Tuesday, hitting $105.48. The stock had a trading volume of 4,339,811 shares, compared to its average volume of 3,179,274. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $113.85. The firm’s 50-day moving average is $70.87 and its two-hundred day moving average is $60.05.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The company had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs’s revenue was up 47.1% on a year-over-year basis. On average, analysts predict that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.
Institutional Investors Weigh In On Astera Labs
Analysts Set New Price Targets
A number of equities analysts have commented on ALAB shares. Barclays lifted their price objective on shares of Astera Labs from $70.00 to $87.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Morgan Stanley increased their price target on shares of Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Craig Hallum upped their price objective on Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price objective on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Finally, Citigroup began coverage on Astera Labs in a research report on Monday, November 18th. They set a “buy” rating and a $120.00 target price on the stock. Twelve investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $94.67.
View Our Latest Stock Analysis on ALAB
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- What Are Dividend Contenders? Investing in Dividend Contenders
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- The Significance of Brokerage Rankings in Stock Selection
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Start Investing in Real Estate
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.